CARRICK THERAPEUTICS
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most aggressive and resistant forms of cancer using innovative mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from early stage.
CARRICK THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.carricktherapeutics.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Apache Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Amyloid Solution
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Exciva
German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development.
Oxford Vacmedix
Develop therapeutic agents for the treatment of cancer .
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
PolyProx
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Rodeo Therapeutics
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
Spiraldynamik
Spiraldynamik is an anatomically based movement and therapy concept, an instruction manual for the own body from head to toe.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series A - Carrick Therapeutics
Woodford Investment Management
Woodford Investment Management investment in Series A - Carrick Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Carrick Therapeutics
Evotec
Evotec investment in Series A - Carrick Therapeutics
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Series A - Carrick Therapeutics
Lightstone Ventures
Lightstone Ventures investment in Series A - Carrick Therapeutics
GV
GV investment in Series A - Carrick Therapeutics
Official Site Inspections
http://www.carricktherapeutics.com
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Carrick Therapeutics"
About - Carrick Therapeutics, Inc.
Building a solid foundation for novel cancer therapies. Carrick Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for aggressive and resistant forms of cancer.See details»
Carrick Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most …See details»
Carrick Therapeutics Company Profile 2024: Valuation, …
Carrick Therapeutics General Information Description. Developer of cancer therapeutics designed to change the cancer patients treatment and the lives. The company's therapeutics target molecular pathways that drive away aggressive …See details»
Establishment of US operations and new CEO - Carrick …
Jun 28, 2019 CARRICK THERAPEUTICS ANNOUNCES PLAN TO ESTABLISH US OPERATIONS AND APPOINTMENT OF TIM PEARSON AS CEO DUBLIN, Ireland, 28 June …See details»
Carrick Therapeutics - LinkedIn
Carricktherapeutics.com 15 1 Comment Like Comment Share Carrick Therapeutics 2,610 followers 1mo Report this post https://lnkd.in/eKFiHmqM. Carrick Therapeutics Announces …See details»
Creating a premier oncology biotech company in …
Carrick Therapeutics. Elaine Sullivan, CEO, Carrick Therapeutics, Dublin, Ireland, Tel: +353 1 716 3620, Website: www.carricktherapeutics.comSee details»
Carrick Therapeutics - LinkedIn
Carrick Therapeutics | 2,206 followers on LinkedIn. Transformative Cancer Medicines | Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target …See details»
Carrick Therapeutics - Craft
Carrick Therapeutics has 5 employees across 2 locations and $95 m in total funding,. See insights on Carrick Therapeutics including office locations, competitors, revenue, financials, …See details»
Carrick Therapeutics - Overview, News & Similar companies
Dec 18, 2022 Who is Carrick Therapeutics. Carrick Therapeutics was founded in 2016, it has a clear vision for cancer patients: to target the molecular pathways that drive the most aggressiv …See details»
Carrick Therapeutics Establishes New Headquarters in Boston ...
Jun 5, 2024 Appoints David Sutherland, CPA, as Vice President of Finance and Controller. BOSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Carrick Therapeutics Inc., an oncology …See details»
Carrick Therapeutics and The Menarini Group Announce Clinical …
Carrick to execute Phase 2 clinical trial in patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer (DUBLIN, Ireland and FLORENCE, Italy, December 19, 2022) - Carrick …See details»
Carrick Therapeutics Receives FDA Fast Track Designations for Two ...
Aug 16, 2021 DUBLIN, Ireland and BOSTON, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing …See details»
Carrick Therapeutics Announces $35 Million Investment from Pfizer
Dec 1, 2022 Funding supports advancement of samuraciclib, an oral CDK7 inhibitor, in combination with endocrine therapy for HR+, HER2- advanced breast cancer Adam …See details»
Company Information - Carrick Therapeutics Limited
Contact Information. Email Alerts; Company Profile; Contacts; RSS News Feed; 2024 Carrick Therapeutics Limited. All Rights Reserved.See details»
Carrick Therapeutics Announces Collaboration with Roche to
Aug 2, 2021 DUBLIN, Ireland and BOSTON, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing …See details»
Recommended Stories - Yahoo Finance
BOSTON, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today …See details»
Investors - Carrick Therapeutics, Inc.
Sep 23, 2024 Email Alerts. Stay informed and receive company updates straight to your inbox. Sign up todaySee details»
Carrick Therapeutics to Present Clinical Data on - GlobeNewswire
Nov 22, 2021 DUBLIN, Ireland and BOSTON, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing …See details»
Carrick Therapeutics Announces Clinical Trial Collaboration with ...
Jul 6, 2023 Collaboration expands Carrick’s clinical-stage Oncology program. DUBLIN, Ireland and BOSTON, July 06, 2023 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology …See details»